Literature DB >> 32946062

Osteoporotic Conditions Influence the Activity of Adipose-Derived Stem Cells.

Jeong Seop Park1, Jiyuan Piao2, Gabee Park2, Kyung Sang Yoo2, Hyun Sook Hong3,4,5.   

Abstract

BACKGROUND: Estrogen deficiency decreases bone density and increases the risk of osteoporosis and fracture, thereby necessitating reconstruction of bone regeneration. As bone marrow mesenchymal stem cell (BMSCs) lose viability and differentiation potential under osteoporotic conditions, it is impossible to use autologous BMSCs for osteoporosis treatment. As an alternative, adipose-derived stem cells (ADSCs) may serve as the source of therapeutic cells.
METHOD: We evaluated the effects of osteoporosis on the functional characteristics of ADSCs. Osteoporosis was induced in ovariectomy (OVX) rat model, and the ADSCs from Sham and OVX groups were cultured and analyzed comparatively.
RESULTS: As a result, the viability was higher for the ADSCs from Sham group than those from OVX group. The analysis of the paracrine potential of ADSCs revealed the elevated levels of inflammatory and cellular senescence factors in the ADSCs from OVX group. The ADSCs from OVX group had much higher differentiation potential into adipocytes than those from the Sham group. Osteoporotic environment had no effect on the osteogenic potential of ADSCs.
CONCLUSION: Osteoporosis may reduce the activity and influence immune response of ADSCs by modulating paracrine action and adipogenic potential. These characteristics of ADSCs should be given consideration for therapeutic purpose.

Entities:  

Keywords:  Adipose-derived stem cell; Differentiation; Osteoporosis; Paracrine action

Year:  2020        PMID: 32946062      PMCID: PMC7710784          DOI: 10.1007/s13770-020-00289-x

Source DB:  PubMed          Journal:  Tissue Eng Regen Med        ISSN: 1738-2696            Impact factor:   4.169


  37 in total

1.  Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

Authors:  S Cenci; M N Weitzmann; C Roggia; N Namba; D Novack; J Woodring; R Pacifici
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Bone-graft harvesting from iliac and fibular donor sites: techniques and complications.

Authors:  N A Ebraheim; H Elgafy; R Xu
Journal:  J Am Acad Orthop Surg       Date:  2001 May-Jun       Impact factor: 3.020

3.  Bisphosphonate-induced osteopetrosis.

Authors:  Michael P Whyte; Deborah Wenkert; Karen L Clements; William H McAlister; Steven Mumm
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

Review 4.  Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.

Authors:  R Fliefel; M Tröltzsch; J Kühnisch; M Ehrenfeld; S Otto
Journal:  Int J Oral Maxillofac Surg       Date:  2015-02-26       Impact factor: 2.789

5.  Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis.

Authors:  S X Zheng; Y Vrindts; M Lopez; D De Groote; P F Zangerle; J Collette; N Franchimont; V Geenen; A Albert; J Y Reginster
Journal:  Maturitas       Date:  1997-01       Impact factor: 4.342

6.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.

Authors:  Wolfgang Wagner; Frederik Wein; Anja Seckinger; Maria Frankhauser; Ute Wirkner; Ulf Krause; Jonathon Blake; Christian Schwager; Volker Eckstein; Wilhelm Ansorge; Anthony D Ho
Journal:  Exp Hematol       Date:  2005-11       Impact factor: 3.084

7.  Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model.

Authors:  Changchun Ren; Sanjay Kumar; Diptiman Chanda; Jian Chen; John D Mountz; Selvarangan Ponnazhagan
Journal:  Stem Cells       Date:  2008-07-10       Impact factor: 6.277

8.  Treating osteoporosis by targeting parathyroid hormone to bone.

Authors:  T Ponnapakkam; R Katikaneni; J Sakon; R Stratford; R C Gensure
Journal:  Drug Discov Today       Date:  2013-08-06       Impact factor: 7.851

Review 9.  Primary osteoporosis in postmenopausal women.

Authors:  Meng-Xia Ji; Qi Yu
Journal:  Chronic Dis Transl Med       Date:  2015-03-21

10.  Human adipose-derived mesenchymal stem cells seeded into a collagen-hydroxyapatite scaffold promote bone augmentation after implantation in the mouse.

Authors:  Giovanna Calabrese; Raffaella Giuffrida; Stefano Forte; Claudia Fabbi; Elisa Figallo; Lucia Salvatorelli; Lorenzo Memeo; Rosalba Parenti; Massimo Gulisano; Rosario Gulino
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

View more
  6 in total

1.  Transcriptomic analysis and biological evaluation reveals that LMO3 regulates the osteogenic differentiation of human adipose derived stem cells via PI3K/Akt signaling pathway.

Authors:  Yue Kang; Wenye Pei
Journal:  J Mol Histol       Date:  2022-02-14       Impact factor: 2.611

2.  Bi-directional gene activation and repression promote ASC differentiation and enhance bone healing in osteoporotic rats.

Authors:  Vu Anh Truong; Ya-Hui Lin; Nuong Thi Kieu Nguyen; Mu-Nung Hsu; Nam Ngoc Pham; Yi-Hao Chang; Chin-Wei Chang; Chih-Che Shen; Hsiang-Sheng Lee; Po-Liang Lai; Yelena V Parfyonova; Mikhail Menshikov; Jaw-Ching Wu; Yu-Han Chang; Yu-Chen Hu
Journal:  Mol Ther       Date:  2021-08-25       Impact factor: 11.454

3.  Priming with a Combination of FGF2 and HGF Restores the Impaired Osteogenic Differentiation of Adipose-Derived Stem Cells.

Authors:  Jeong Seop Park; Doyoung Kim; Hyun Sook Hong
Journal:  Cells       Date:  2022-06-27       Impact factor: 7.666

4.  Knowledge and Beliefs on Osteoporosis among African Postmenopausal Women in a Kenyan Semi-Rural County of Kiambu.

Authors:  Fred Chuma Sitati; Madadi Moses Obimbo; Peter Gichangi
Journal:  J Bone Metab       Date:  2021-02-28

5.  Knockdown of PDX1 enhances the osteogenic differentiation of ADSCs partly via activation of the PI3K/Akt signaling pathway.

Authors:  Fan Liu; Guang-Dong Chen; Long-Kun Fan
Journal:  J Orthop Surg Res       Date:  2022-02-19       Impact factor: 2.359

Review 6.  The therapeutic potential of mesenchymal stem cells in treating osteoporosis.

Authors:  Tianning Chen; Tieyi Yang; Weiwei Zhang; Jin Shao
Journal:  Biol Res       Date:  2021-12-20       Impact factor: 5.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.